skip to main content

Our response to the Covid-19 outbreak.

Webinar — COVID-19 Vaccines: Clinical Trials, Approval and Addressing Public Hesitancy

Over time, U.S. vaccine policy has moved from a science and public health issue to one involving the perceived infringement of civil liberties. Assertions of an individual’s right to self-determination, at times accompanied by scientific misinformation, have been set against effective, efficient strategies for community-wide protection. The controversies surrounding the development and future use of a COVID-19 vaccine illustrate this shift. At this event, health policy fellow Dr. Peter Hotez and vaccine expert Dr. Peter Marks will discuss the vaccine approval process, including clinical trials and the U.S. Food and Drug Administration review process. Using the COVID-19 vaccine as an example, panelists will also discuss public hesitancy and ways to improve public trust in vaccines.  

This event is co-sponsored by the Baker Institute Science and Technology Policy Program, The Immunization Partnership and Community Health Choice, with generous support from the Kavli Foundation and the National Science Foundation (Grant No. 2042854). Follow @stpolicy on Twitter and join the conversation with #BakerScience.

 


Agenda

12:00 p.m. — Welcome Remarks
12:05 p.m. — Moderated Discussion and Q&A


Registration

This webinar is free, but registration is required. Please click here to register.


Welcome Speaker

Kirstin R.W. Matthews, Ph.D.
Fellow in Science and Technology Policy, Baker Institute


Featured Speakers

Peter Hotez, M.D., Ph.D.
Fellow in Disease and Poverty, Baker Institute; Dean, National School of Tropical Medicine, Baylor College of Medicine

Peter Marks, M.D., Ph.D.
Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration


Moderator

Rekha Lakshmanan
Contributing Expert, Center for Health and Biosciences, Baker Institute; Director of Advocacy and Policy, The Immunization Partnership

 

 

 

When?

Tue, Dec. 8, 2020
noon - 1 p.m.
(GMT-0600) US/Central

Where?

Online webinar